High-intensity ultrasound, the kind pioneered by researchers like the Fry brothers, has already carved out a niche in modern medicine. It’s an approved treatment for a handful of stubborn conditions, from shrinking uterine fibroids to tackling certain prostate cancers. It can even help calm the tremors of Parkinson’s disease when medication falls short. But there’s a gentler side to this technology, a low-intensity version that doesn’t destroy tissue but instead gently nudges brain activity. This softer approach is what has captured the imagination of Dr. Ali Rezai and his team. They aren’t looking to burn away problems; they’re hoping to tune them, to quiet the static in a specific, deep-brain region that’s been implicated in addiction.
The real allure of this low-intensity ultrasound is its surgical precision without the surgery. The brain is a fortress, and the skull is its thick, defensive wall. Other noninvasive techniques, like transcranial magnetic stimulation, can only really penetrate the outer layers of the brain, the cortex. They can’t reach the deeper, more primitive structures that drive our cravings and impulses. Rezai’s target, the nucleus accumbens, is a tiny, pea-sized cluster of neurons buried deep in the brain, a key player in the reward circuit that makes addiction so tenacious. This little region is the chemical engine of desire, and low-intensity focused ultrasound can reach it, even through the intact skull, without a single incision. That’s the promise that has Rezai so excited—the possibility of directly influencing the brain’s reward system without any of the risks of invasive surgery.
This was the premise for his 2021 exploratory trial at West Virginia University. With approval from the Food and Drug Administration, Rezai’s team began testing the safety of this approach on volunteers battling addiction. They used a machine designed for powerful, tissue-destroying ultrasound but turned the power way down, administering a low dose and gradually increasing it to find a safe, effective level. The goal wasn’t to zap anything away, but to softly stimulate the nucleus accumbens and see if it could disrupt the pathological craving that defines addiction. The results were dramatic, even for the researchers. Patients reported their cravings plummeting right on the table, a nearly immediate change that felt both profound and strange. They described a feeling of being different, of a mental quietness they hadn’t experienced in years, as if the frantic, automatic “need” for their drug had been suddenly dialed down.
This is where the story of the technology becomes a story of a person. Linda, a mother from Vermont, heard about Rezai’s work and saw it as a beacon of hope for her daughter, Erin, who had been struggling with methamphetamine addiction for years. Linda had watched her daughter’s life unravel, the addiction consuming everything in its path. Erin described it as an absolute takeover—the overwhelming drive to get more meth outweighed all else, including her love for her own child. She was a mother, but the addiction made even that role secondary to the relentless pursuit of the next high. She wanted to stop, desperately, but she couldn’t imagine a life without the drug. When Linda told her about the study, Erin was cautiously hopeful, but deeply frightened. She latched onto the video of the procedure, watching it over and over, trying to find the courage to commit.
The logistics of getting to the trial were a battle in themselves. To be considered, Erin had to be in active treatment within the WVU system, which meant getting her from their home in Vermont to Morgantown, West Virginia—a journey that involved a flight to Pittsburgh and an hour-and-a-half drive. For most people, it’s a simple trip. For someone in the grip of a powerful addiction, it was an ordeal. They tried to fly twice before, but Erin couldn’t make it. Anxiety and the pull of her addiction would overwhelm her, and she’d find an excuse—a missed flight, a trip to the bathroom—to escape back to the familiar, albeit destructive, life she knew. The third time, Erin’s daughter held her hand during the entire boarding process and didn’t let go. They finally made it to Morgantown, and in April 2024, Erin checked into the Center for Hope and Healing, a residential facility affiliated with WVU that was recruiting for Rezai’s study.
Even after arriving, the emotional weight was crushing. When her mother and daughter left her there, Erin was miserable, consumed by loneliness, fear, and the gnawing uncertainty of what lay ahead. She was walking into the unknown, leaving behind everything she knew, even the painful familiarity of her addiction. She had come this far, and the only thing waiting for her on the other side was a question the researchers themselves couldn’t answer yet: would this experimental ultrasound procedure, a soft whisper of sound aimed at a pea-sized part of her brain, be the thing that finally set her free?
